Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Male

Explore clinical trials studying Genital Neoplasms, Male. Study availability and eligibility vary by location and protocol.

5,077 public trials 1,036 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Male trial results

Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT03866382

Conditions
Adenocarcinoma, Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, +71 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 581 locations
View Trial Details
Recruiting

Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer

NCT05448547

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Rigshospital Copenhagen, Denmark
  • Esbjerg and Grindsted Hospital Esbjerg, Denmark
  • Odense University Hospital Odense, Denmark
  • Helsinki University Hospital Helsinki, Finland
View all 26 locations
View Trial Details
Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

NCT05946213

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Lewis and Faye Manderson Cancer Center Tuscaloosa, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 413 locations
View Trial Details
Recruiting

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

NCT06440005

Conditions
Advanced Cancer, Angiosarcoma, Breast Cancer, +46 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Florida Cancer Specialist Sarasota, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Sarah Cannon Research Center Nashville, Tennessee, United States
View Trial Details

Related conditions